LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

Search

Zoetis Inc

Closed

Sector Healthcare

189.59 1.82

Overview

Share price change

24h

Current

Min

188.85

Max

190.41

Key metrics

By Trading Economics

Income

25M

624M

Sales

160M

2.4B

P/E

Sector Avg

33.4

103.001

EPS

1.56

Profit margin

26.441

Employees

14,100

EBITDA

35M

966M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+15.15 upside

Dividends

By Dow Jones

Next Earnings

31 paź 2024

Next Dividend date

29 lis 2024

Next Ex Dividend date

29 paź 2024

Market Stats

By TradingEconomics

Market Cap

84B

Previous open

187.77

Previous close

189.59

News Sentiment

By Acuity

54%

46%

285 / 365 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bullish Evidence

Zoetis Inc Chart

Related News

6 sie 2024, 11:52 UTC

Earnings

Zoetis Raises Guidance After 2Q Sales, Earnings Rise

29 kwi 2024, 10:57 UTC

Acquisitions, Mergers, Takeovers

Zoetis to Sell Medicated-Feed-Additive Portfolio to Phibro for $350 Million

12 kwi 2024, 11:47 UTC

Major Market Movers

Zoetis Shares Slip Premarket After WSJ Report on Arthritis Drugs for Pets

13 lut 2024, 12:36 UTC

Earnings

Zoetis 4Q Net Up 14%, Sees 2024 Growth on Strong Pet, Livestock Demand

6 sie 2024, 11:44 UTC

Earnings

Zoetis Earnings Growth Picks Up, Tops Views -- IBD

6 sie 2024, 11:09 UTC

Earnings

Zoetis Raises 2024 Operational Revenue Growth View to 9%-11% >ZTS

6 sie 2024, 11:08 UTC

Earnings

Zoetis Raises 2024 View To Adj EPS $5.78-Adj EPS $5.88 >ZTS

6 sie 2024, 11:08 UTC

Earnings

Zoetis Raises 2024 View To Rev $9.1B-$9.25B >ZTS

6 sie 2024, 11:08 UTC

Earnings

Zoetis 2Q Adj EPS $1.56 >ZTS

6 sie 2024, 11:00 UTC

Earnings

Zoetis 2Q Net $624M >ZTS

6 sie 2024, 11:00 UTC

Earnings

Zoetis 2Q Rev $2.36B >ZTS

6 sie 2024, 11:00 UTC

Earnings

Zoetis 2Q EPS $1.37 >ZTS

2 maj 2024, 17:43 UTC

Earnings

Zoetis Stock Climbs on Earnings Beat, but Worries Linger Over Key Medicine -- Barrons.com

2 maj 2024, 13:06 UTC

Earnings

Zoetis Stock Climbs on Earnings Beat, but Worries Linger Over Key Medicine -- Barrons.com

2 maj 2024, 11:27 UTC

Earnings

Zoetis Earnings Top; Pet Drugmaker Rises -- IBD

2 maj 2024, 11:00 UTC

Earnings

Zoetis 1Q Net $599M >ZTS

2 maj 2024, 11:00 UTC

Earnings

Zoetis 1Q EPS $1.31 >ZTS

2 maj 2024, 11:00 UTC

Earnings

Zoetis 1Q Rev $2.19B >ZTS

12 kwi 2024, 20:37 UTC

Earnings

These Stocks Moved the Most Today: JPMorgan Chase, Citigroup, AMD, Intel, Arista Networks, Zoetis, and More -- Barrons.com

13 lut 2024, 12:02 UTC

Earnings

Zoetis Sees 2024 Adj EPS $5.74-Adj EPS $5.84 >ZTS

13 lut 2024, 12:02 UTC

Earnings

Zoetis Sees 2024 EPS $5.34-EPS $5.44 >ZTS

13 lut 2024, 12:01 UTC

Earnings

Zoetis Sees 2024 Net $2.468B-Net $2.513B >ZTS

13 lut 2024, 12:01 UTC

Earnings

Zoetis Sees 2024 Rev $9.075B-$9.225B >ZTS

13 lut 2024, 12:00 UTC

Earnings

Zoetis 4Q EPS $1.14 >ZTS

13 lut 2024, 12:00 UTC

Earnings

Zoetis 4Q Rev $2.21B >ZTS

13 lut 2024, 12:00 UTC

Earnings

Zoetis 4Q Net $525M >ZTS

2 lis 2023, 11:08 UTC

Earnings

Zoetis Updates FY23 EPS Guidance Due to Impact of Foreign Exchange Rates >ZTS

2 lis 2023, 11:08 UTC

Earnings

Zoetis Sees FY23 Adj EPS $5.38-Adj EPS $5.43 >ZTS

2 lis 2023, 11:08 UTC

Earnings

Zoetis Sees FY23 EPS $5.14-EPS $5.21 >ZTS

2 lis 2023, 11:07 UTC

Earnings

Zoetis Sees FY23 Net $2.38B-Net $2.415B >ZTS

Peer Comparison

Price change

Zoetis Inc Forecast

Price Target

By TipRanks

15.15% upside

12 Months Forecast

Average 217.9 USD  15.15%

High 248 USD

Low 200 USD

Based on 10 Wall Street analysts offering 12 month price targets forZoetis Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

10 ratings

10

Buy

0

Hold

0

Sell

Technical Score

By Trading Central

182.9381 / N/ASupport & Resistance

Short Term

Very Strong Bullish Evidence

Intermediate Term

Strong Bullish Evidence

Long Term

Strong Bullish Evidence

Sentiment

By Acuity

285 / 365 Ranking in Healthcare

News Sentiment

Bearish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Zoetis Inc

Zoetis Inc. is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products, biodevices, genetic tests and precision livestock farming technology. The Company has a business, commercializing products across eight core species: dogs, cats and horses (collectively, companion animals) and cattle, swine, poultry, fish and sheep (collectively, livestock); and within product categories such as vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. The Company's segments include the United States and International. Within each of these operating segments, it offers a product portfolio for both livestock and companion animal customers.